Join AZBioPEERS for a conversation with the National Cancer Institute (NCI) focused on the evolving SBIR/STTR funding landscape and new opportunities for life science and health innovation companies.

The webinar will highlight key changes following the 2026 SBIR/STTR reauthorization, provide an overview of NCI SBIR’s funding pipeline from early concept through commercialization, and explore mechanisms such as Fast Track, Direct-to-Phase II, and the Phase IIB Bridge Award. The discussion will also introduce the new Strategic Breakthrough Awards, including how they are designed to support regulatory readiness, commercial potential, clinical translation, and private-sector investment.

Attendees will gain practical insight into how to navigate NCI SBIR funding opportunities, position their companies for future applications, and take advantage of resources designed to help promising technologies move from development toward real-world impact.

Attendees may schedule one-on-one meetings with NCI Program Directors in advance. These individual meetings will begin immediately following the webinar. Contact Dylan Peay, PhD (dylan@azadvances.org) for the bookings link.

Tuesday, November 17, 2026

8:00 am - 9:00 am AZ

on Zoom